Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : JNNE Jones Naughton: Go Online via Kiosk -- Ignore unavailable to you. Want to Upgrade?

To: Americo Burgos III who wrote (750)	4/10/1999 4:30:00 PM
From: Terry D.	Respond to of 4824

If you take our earning/market cap/potential, we are really undervalued when you compare Ebay, Yahoo or any of the internet stocks. P/E's of 200 to 1 with no positive earnings. It is all based on PERCEPTION. Perception of what can or may be. What is the PERCEPTION of JNNE and it's future? According to last weeks action, I would say it is very good. Someone posted asking what was someones idea of long term. I, along with a few others have been holding JNNE for 4 years+. Why? Because we had the PERCEPTION that management was good and long term prospects were good. OT You might want to check out another undervalued company. TCLN (Techniclone) Selling for $1.00. They have 3 drugs in trials for NHL. Phase I, Phase II, and Phase III. Go to their website and look under technology and news link. Their LYM I was featured in a WMAQ Chicago news interview last week. Two women with terminal cancer are in complete remission. The company was interviewed by the Boston Globe last Thursday, they signed a licensing deal with Sherling AG for their Oncolym (LYM I) and hold tight patents on VTA and VEA therapies. These are the ones you've been reading about, angiogensis. Starving tumors blood supply. Luck to all in your investments Tery